Keyword: Torrent Pharmaceuticals
Merck halves Keytruda's price in China; Takeda eyes selling Shire's Xiidra and Natpara; another ex-GSK scientist pleads guilty to trade secret theft.
Drug materials are targets of U.S.-China trade war, analysts see more hope in the Takeda-Shire deal, China puts forward policies that favors generics over brands.
As Sanofi presses ahead with the sale of its EU generics unit, a private equity firm has reportedly bowed out over price.
Sanofi, aiming to sharpen its focus by offloading its EU generics, is reportedly drawing shoppers from across the globe. The deal could be worth $2B.
Novo Nordisk and Indian partner Torrent Pharmaceuticals will expand insulin production in India.
The list of drugmakers reportedly eying Bayer’s up-for-sale dermatology unit is growing even longer.
India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player.